Common questions / answered and cited
Semaglutide: common questions, answered from the record
Direct answers drawn from the trials and the safety literature, each cited to its source.
What are the side effects of semaglutide?
The dominant side effects are gastrointestinal — nausea, vomiting, diarrhea and constipation — and in the pooled weight-management analysis they were predominantly mild-to-moderate and transient, concentrated around dose escalation [8]. A safety review put nausea at roughly one in three patients and also flagged increased gallbladder disease [5]. Real-world reporting is likewise dominated by gut events [22].
Does semaglutide make you tired?
Tiredness is not among the dominant, drug-specific adverse effects in the trials, which are gastrointestinal [5]. In patient communities, fatigue is commonly reported in the first day or two after a dose and during the early weeks, often easing with time — but those are anecdotal accounts, not a measured trial outcome, and frequently overlap with eating and drinking less.
Does semaglutide cause hair loss?
A pharmacovigilance analysis found a reporting signal for hair loss (alopecia) with semaglutide and tirzepatide, interpreted as telogen effluvium from rapid weight loss rather than a direct drug effect [17]. A dermatology study separately linked that shedding to the size and speed of weight loss [18]. It is described as temporary. See the semaglutide hair loss page.
What is the downside of semaglutide?
The main downsides are gastrointestinal intolerance, especially during titration [8]; weight regain after stopping (a mean ~11.6 percentage points within a year in the STEP 1 extension) [15]; and loss of some lean mass alongside fat [14]. Hard cautions include a boxed thyroid warning and a pancreatitis class warning [5][13].
What should you not mix with semaglutide?
A systematic review found GLP-1 receptor agonists generally do not cause clinically significant interactions despite slowing stomach emptying, but advised caution and monitoring for narrow-therapeutic-index oral drugs during dose escalation [21]. A dedicated study found no clinically relevant effect on metformin, warfarin, atorvastatin or digoxin levels [12]. This is general information, not medical advice.
Does semaglutide cause pancreatitis or thyroid cancer?
Acute pancreatitis is a class warning, and treatment is stopped if it is suspected; a thyroid C-cell-tumor boxed warning comes from rodent studies [5]. A 2024 assessment found no clear human thyroid-cancer signal [13], and the safety review notes pancreatic-cancer signals remain unconfirmed given low incidence [5]. A family history of medullary thyroid carcinoma is a contraindication.
What is semaglutide?
Semaglutide is a GLP-1 receptor agonist — a medicine that activates the same receptor as the natural gut hormone GLP-1 to boost insulin when blood sugar is high, suppress glucagon, slow stomach emptying and reduce appetite [4]. It is a 31-amino-acid analogue of human GLP-1, engineered to last about a week, given as a weekly injection or a daily tablet.
What is semaglutide used for?
Semaglutide is FDA-approved for type 2 diabetes, chronic weight management, reducing major adverse cardiovascular events in people with established cardiovascular disease, and (since 2025) a serious fatty-liver disease (MASH). The pivotal evidence includes STEP 1 for weight [1], SUSTAIN-6 and SELECT for cardiovascular outcomes [2][3], and FLOW for kidney outcomes [6].
How does semaglutide work?
It activates GLP-1 receptors across the pancreas, gut and brain: boosting glucose-dependent insulin release, suppressing glucagon, slowing stomach emptying, and — the main driver of weight loss — reducing appetite via brain circuits. A rodent study mapped its access to the brainstem and hypothalamic appetite centers, cutting intake without lowering energy expenditure [4].
How does semaglutide work for weight loss?
The weight effect is mostly central: semaglutide reaches appetite-control regions including the hypothalamic arcuate nucleus and the brainstem area postrema, turning up satiety signaling and turning down hunger signaling, which reduces food intake — without increasing calorie burn [4]. In STEP 1, this produced a mean -14.9% body-weight change at 68 weeks versus -2.4% on placebo [1].
What is the semaglutide dosage for weight loss?
In STEP 1, the chronic-weight-management trial, the maintenance dose was once-weekly subcutaneous semaglutide 2.4 mg, reached by stepping up gradually from 0.25 mg over several weeks [1]. That figure is reported as the trial used it, not as a recommendation — dosing is a decision for a prescriber. See the dosage page.
How many mg is 40 units of semaglutide?
This site does not convert "units" to milligrams or provide dosing instructions, because that is exactly the kind of administration math that belongs with a prescriber and the approved labeling. Unit-based measuring of semaglutide is a known source of dosing errors, particularly with non-standard products [5]. The mg figures here are reported only as the trials documented them.
What is compounded semaglutide?
Compounded semaglutide is prepared by a compounding pharmacy rather than the approved manufactured product; it was permitted during a declared shortage and falls outside the approved product's evidence base. The safety literature emphasizes documented quality and safety concerns with compounded or non-pharmaceutical sources [5]. The pathway was curtailed after the shortage was declared resolved in 2025.
How long does it take for semaglutide to work?
Effects build over weeks because the dose is escalated slowly. Appetite changes are often noticed early, but the pivotal weight result is measured over the long run: STEP 1 reported its mean -14.9% body-weight change at week 68 [1]. The slow titration is deliberate — it keeps the gastrointestinal side effects, concentrated around dose increases, more manageable [8].
How long does semaglutide stay in your system?
Semaglutide's elimination half-life is approximately one week (commonly cited as about 165–168 hours), with effectively complete clearance roughly five weeks after the last dose. This long persistence is why a low drug-interaction risk was confirmed for co-administered metformin, warfarin, atorvastatin and digoxin [12], and why a multi-week washout is advised before a planned pregnancy [19].
What is the half-life of semaglutide?
About one week — commonly cited as roughly 165–168 hours — for both the injectable and oral forms, with full clearance about five weeks after the final dose. The long half-life comes from tight, reversible binding to albumin via the fatty-acid side chain plus resistance to the DPP-4 enzyme, which together enable once-weekly dosing [12][19].
Is oral semaglutide as effective as the injection?
Oral and injectable semaglutide are different formulations; the oral tablet is absorbed poorly (bioavailability ~0.4–1%) and needs strict fasted dosing [20]. Higher oral doses have been developed to compensate: PIONEER PLUS found 25 mg and 50 mg oral doses improved glycemic control and weight versus 14 mg in type 2 diabetes [10]. Effectiveness depends heavily on correct fasted administration.
How long does it take for semaglutide to suppress appetite?
Appetite suppression is the mechanism people tend to notice earliest, since semaglutide acts directly on brain appetite circuits to reduce food intake [4]. The intensity tracks dose escalation rather than appearing fully at once. Patient accounts often describe reduced "food noise" within the first weeks, but those are anecdotal, and the trials measured weight, not the timing of appetite change.
Why am I not losing weight on semaglutide?
This site does not give individual guidance, but the trial context helps frame the question. STEP 1 reported a mean -14.9% change at 68 weeks — an average, with real individual variation around it [1]. Dose, how far titration has progressed, and how the oral form is taken all matter; the weight effect also depends on continued treatment, since stopping is followed by regain [15].
Is semaglutide a GLP-1?
Yes. Semaglutide is a GLP-1 receptor agonist — a medicine that activates the glucagon-like peptide-1 (GLP-1) receptor, the same one the natural gut hormone GLP-1 uses [4]. It is a long-acting analogue of human GLP-1, structurally about 94% identical, engineered to resist breakdown so it lasts about a week instead of minutes.
How fast does semaglutide work?
Quickly in terms of appetite signaling — it acts on brain circuits to reduce intake [4] — but the measurable weight outcome is a long-run figure: STEP 1's mean -14.9% was reported at 68 weeks [1]. The dose is escalated over weeks on purpose, to keep titration-related gastrointestinal effects manageable, so the full effect is not immediate [8].
What is the difference between semaglutide and tirzepatide?
Semaglutide is a single GLP-1 receptor agonist; tirzepatide is a dual agonist that activates both the GIP and GLP-1 receptors. In the SURMOUNT-5 head-to-head trial of adults with obesity, tirzepatide produced greater mean weight loss at 72 weeks (-20.2% vs -13.7%; P<0.001) [7]. Semaglutide, though, carries the larger long-term cardiovascular and kidney outcome dataset.